These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2078995)

  • 21. Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection?
    Menasché P; Kevelaitis E; Mouas C; Grousset C; Piwnica A; Bloch G
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1606-13; discussion 1613-4. PubMed ID: 8523870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [K-channel activators and cardioprotection].
    Specchia G; Marsico F; Laudisa ML
    Cardiologia; 1993 Dec; 38(12 Suppl 1):453-7. PubMed ID: 8020047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential therapeutic role of potassium channel modulators in asthma and chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Mancuso S; Polosa R
    J Biol Regul Homeost Agents; 2010; 24(2):123-30. PubMed ID: 20487625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective beta-adrenoceptor agonists, calcium antagonists and potassium channel openers as a possible medical treatment of the overactive bladder and urge incontinence.
    Badawi JK; Langbein S
    Pharmazie; 2006 Mar; 61(3):175-8. PubMed ID: 16599254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implications in cardioplegia.
    López JR; Jahangir R; Jahangir A; Shen WK; Terzic A
    J Thorac Cardiovasc Surg; 1996 Sep; 112(3):820-31. PubMed ID: 8800173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KATP channel openers: structure-activity relationships and therapeutic potential.
    Mannhold R
    Med Res Rev; 2004 Mar; 24(2):213-66. PubMed ID: 14705169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interference of uptake of thallium-201 in cultured rat myocardial cells with existence of potassium related pharmaceuticals--a preliminary report.
    Chen YW; Yeh JL; Huang YC; Chen IJ; Huang YF; Liu GC
    Kaohsiung J Med Sci; 2000 Mar; 16(3):134-40. PubMed ID: 10846349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of preterm labour.
    Vause S; Johnston T
    Arch Dis Child Fetal Neonatal Ed; 2000 Sep; 83(2):F79-85. PubMed ID: 10952696
    [No Abstract]   [Full Text] [Related]  

  • 29. ATP-regulated K+ channel in mitochondria: pharmacology and function.
    Szewczyk A; Czyz A; Wojcik G; Wojtczak L; Nalecz MJ
    J Bioenerg Biomembr; 1996 Apr; 28(2):147-52. PubMed ID: 9132413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium channel agonists modify the local anaesthetic activity of bupivacaine in mice.
    Gantenbein M; Attolini L; Bruguerolle B
    Can J Anaesth; 1996 Aug; 43(8):871-6. PubMed ID: 8840069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicorandil safety in the long-term treatment of coronary heart disease.
    Witchitz S; Darmon JY
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():237-43. PubMed ID: 7647028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats.
    Wanstall JC; O'Donnell SR
    Br J Pharmacol; 1992 Jan; 105(1):152-8. PubMed ID: 1596677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potassium channel openers as potential therapeutic weapons in ion channel disease.
    Lawson K
    Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potassium channel openers induce mitochondrial matrix volume changes via activation of ATP-sensitive K+ channel.
    Szewczyk A; Mikołajek B; Pikuła S; Nałecz MJ
    Pol J Pharmacol; 1993; 45(4):437-43. PubMed ID: 8118486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potassium channel openers. Pharmacological effects and future uses.
    Duty S; Weston AH
    Drugs; 1990 Dec; 40(6):785-91. PubMed ID: 2078995
    [No Abstract]   [Full Text] [Related]  

  • 36. Potassium channel openers exhibit cross-tolerance with morphine in two experimental models of pain.
    Khanna N; Malhotra RS; Mehta AK; Garg GR; Halder S; Sharma KK
    West Indian Med J; 2010 Oct; 59(5):473-8. PubMed ID: 21473392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New activators of potassium channels: design, pharmacology and therapeutic perspectives].
    Pirotte B; Fontaine J; Lebrun P
    J Pharm Belg; 1995; 50(2-3):167-78. PubMed ID: 7674116
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.